Your browser doesn't support javascript.
loading
A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular hemorrhage.
Ye, Lingying; Wu, Ronghan; Li, Jin; Hu, Zhixiang.
Affiliation
  • Ye L; Cataract Department, Eye Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wu R; Fundus Disease Center, Eye Hospital of Wenzhou Medical University, Wenzhou, China.
  • Li J; Cataract Department, Eye Hospital of Wenzhou Medical University, Wenzhou, China.
  • Hu Z; Fundus Disease Center, Eye Hospital of Wenzhou Medical University, Wenzhou, China - zhixianghucn@163.com.
Minerva Med ; 114(4): 573-575, 2023 08.
Article in En | MEDLINE | ID: mdl-35766550

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitrectomy / Hemorrhage Type of study: Clinical_trials Limits: Humans Language: En Journal: Minerva Med Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitrectomy / Hemorrhage Type of study: Clinical_trials Limits: Humans Language: En Journal: Minerva Med Year: 2023 Document type: Article Affiliation country: China